Linking Complement C3 and B Cells in Nasal Polyposis.


Journal

Journal of immunology research
ISSN: 2314-7156
Titre abrégé: J Immunol Res
Pays: Egypt
ID NLM: 101627166

Informations de publication

Date de publication:
2020
Historique:
received: 29 04 2020
accepted: 16 06 2020
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 5 6 2021
Statut: epublish

Résumé

Nasal polyposis often is characterized by a persistent inflammation of the sinonasal mucosa, disease recurrence after medical or surgical intervention, and asthma comorbidity. Dysregulated complement activation may contribute to immunologic alterations and disease. To date, there is only scattered knowledge on the source and regulation of the central complement factors in the pathogenesis of nasal polyps. Here, we aim to study complement signatures, especially the C3-C3aR axis, and focus on cellular sources and targets in nasal polyps. Expression of complement factors, including C3, C5, and the anaphylatoxin receptors, was analyzed in nasal polyp tissue samples, the corresponding inferior turbinates, and healthy controls using transcriptomic methods and protein measurements. Distinct patterns of complement expression were found in nasal polyps compared to controls, characterized by an increased C3 activation and an increase in C3aR-bearing cells. In contrast, no difference was shown for epithelial-dependent C3 production. Besides low intracellular C3-expression levels for lymphocytes in general, we could identify an enlarged B lymphocyte population in nasal polyps displaying high amounts of intracellular C3. Our data suggest a prominent role for the C3-C3aR-axis in nasal polyps and, for the first time, describe a B cell population containing high levels of intracellular C3, suggesting a new role of B cells in the maintenance of the inflammation by complement.

Identifiants

pubmed: 32724828
doi: 10.1155/2020/4832189
pmc: PMC7366218
doi:

Substances chimiques

C3 protein, human 0
Complement C3 0
Receptors, G-Protein-Coupled 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4832189

Informations de copyright

Copyright © 2020 Ulrike Werner et al.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest regarding the publication of this article.

Références

Clin Exp Allergy. 2015 Feb;45(2):328-46
pubmed: 25482020
Mucosal Immunol. 2018 Sep;11(5):1375-1385
pubmed: 29907871
J Immunol. 1984 Nov;133(5):2333-42
pubmed: 6207226
BMC Infect Dis. 2013 May 08;13:210
pubmed: 23656607
J Allergy Clin Immunol. 1993 Feb;91(2):616-22
pubmed: 8436776
J Allergy Clin Immunol. 2017 Jul;140(1):89-100.e2
pubmed: 27979430
Clin Exp Immunol. 2017 May;188(2):183-194
pubmed: 28249350
Semin Nephrol. 2013 Nov;33(6):508-30
pubmed: 24161037
J Immunol Res. 2014;2014:959854
pubmed: 24995349
Allergy. 2013 Jan;68(1):55-63
pubmed: 23157682
Mol Aspects Med. 2006 Apr-Jun;27(2-3):126-39
pubmed: 16469371
Front Immunol. 2019 Mar 19;10:493
pubmed: 30941132
Allergy. 2012 Nov;67(11):1347-56
pubmed: 22978320
Allergy. 2011 Sep;66(9):1216-23
pubmed: 21605125
Clin Exp Allergy. 2017 Apr;47(4):457-466
pubmed: 28000955
J Allergy Clin Immunol. 2009 Aug;124(2):253-9, 259.e1-2
pubmed: 19500825
J Allergy Clin Immunol. 2018 May;141(5):1553-1560
pubmed: 29731101
J Allergy Clin Immunol. 2018 May;141(5):1582-1586.e1
pubmed: 29339260
J Immunol. 1999 Jan 15;162(2):1127-36
pubmed: 9916743
Laryngoscope. 2009 Sep;119(9):1753-8
pubmed: 19572264
Hematol Oncol Clin North Am. 2015 Jun;29(3):479-94
pubmed: 26043387
J Allergy Clin Immunol. 2011 Dec;128(6):1198-1206.e1
pubmed: 21996343
Curr Allergy Asthma Rep. 2013 Apr;13(2):224-8
pubmed: 23247763
Mol Immunol. 2009 Sep;46(14):2753-66
pubmed: 19477527
J Immunol. 2006 Mar 15;176(6):3330-41
pubmed: 16517700
Rhinology. 2012 Mar;50(1):1-12
pubmed: 22469599
Asian Pac J Allergy Immunol. 2012 Sep;30(3):171-6
pubmed: 23156845
Nat Rev Immunol. 2014 Dec;14(12):811-20
pubmed: 25394942
Curr Allergy Asthma Rep. 2015 Jul;15(7):41
pubmed: 26143392
Am J Rhinol Allergy. 2010 Jan-Feb;24(1):21-5
pubmed: 20109314
Immunity. 2013 Dec 12;39(6):1143-57
pubmed: 24315997
J Clin Invest. 2017 Mar 1;127(3):970-981
pubmed: 28192370
Allergy. 2006 Nov;61(11):1280-9
pubmed: 17002703
Ther Clin Risk Manag. 2008 Apr;4(2):507-12
pubmed: 18728843
Clin Exp Allergy. 2007 Dec;37(12):1840-7
pubmed: 17941912
J Allergy Clin Immunol. 2013 Apr;131(4):1075-83, 1083.e1-7
pubmed: 23473835
Int Forum Allergy Rhinol. 2016 Feb;6 Suppl 1:S3-21
pubmed: 26878819
J Immunol. 2002 Nov 15;169(10):5926-33
pubmed: 12421977
J Allergy Clin Immunol. 2012 Nov;130(5):1087-1096.e10
pubmed: 22840853
Cell Tissue Res. 2011 Jan;343(1):227-35
pubmed: 20838815
Laryngoscope. 2004 Apr;114(4):710-9
pubmed: 15064629
Nat Immunol. 2010 Sep;11(9):785-97
pubmed: 20720586
J Allergy Clin Immunol. 2008 Jun;121(6):1385-92, 1392.e1-2
pubmed: 18410958
Am J Rhinol. 2006 Jan-Feb;20(1):117-23
pubmed: 16539307

Auteurs

Ulrike Werner (U)

Department of Otorhinolaryngology, University Hospital Schleswig-Holstein, Campus Lübeck, Germany.

Axel Künstner (A)

Group of Medical Systems Biology, Lübeck Institute of Experimental Dermatology, University of Lübeck, Germany.
Institute for Cardiogenetics, University of Lübeck, Germany.

Maren Drenckhan (M)

Department of Otorhinolaryngology, University Hospital Schleswig-Holstein, Campus Lübeck, Germany.

Ralph Pries (R)

Department of Otorhinolaryngology, University Hospital Schleswig-Holstein, Campus Lübeck, Germany.

Karl-Ludwig Bruchhage (KL)

Department of Otorhinolaryngology, University Hospital Schleswig-Holstein, Campus Lübeck, Germany.

Hauke S Busch (HS)

Group of Medical Systems Biology, Lübeck Institute of Experimental Dermatology, University of Lübeck, Germany.
Institute for Cardiogenetics, University of Lübeck, Germany.

Claus Bachert (C)

Upper Airway Research Laboratory, Department of Otorhinolaryngology, Ghent University Hospital, Belgium.
Division of ENT Diseases, CLINTEC, Karolinska Institute, Stockholm, Sweden.

Barbara Wollenberg (B)

Department of Otorhinolaryngology, University Hospital Schleswig-Holstein, Campus Lübeck, Germany.
Clinic for ENT/HNS, Technical University of Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH